Campbell & Co Investment Adviser’s Roivant Sciences ROIV Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$435K	Buy	+12,303	New	+$364K	0.02%	812
2025 Q4	–	Sell	-35,753	Closed	-$541K	–	1368
2025 Q3	$541K	Sell	35,753 -68,705	-66%	-$851K	0.04%	696
2025 Q2	$1.18M	Buy	104,458 +80,206	+331%	+$869K	0.07%	436
2025 Q1	$245K	Sell	24,252 -53,759	-69%	-$581K	0.02%	894
2024 Q4	$923K	Buy	+78,011	New	+$922K	0.07%	425

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Campbell & Co Investment Adviser's ROIV Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Roivant Sciences (ROIV) in Q2 2026: 12,303 shares worth $435K. The stake represents 0.02% of the portfolio and ranks #812 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in ROIV as recently as Q3 2025.

Campbell & Co Investment Adviser first reported a position in ROIV in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.18M in Q2 2025. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Campbell & Co Investment Adviser held 12,303 shares of Roivant Sciences worth $435K as of Q2 2026.
Roivant Sciences was a new Campbell & Co Investment Adviser position in Q2 2026.
Roivant Sciences made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #812 holding.
Campbell & Co Investment Adviser first reported a position in Roivant Sciences in Q4 2024 and has held it in 5 quarters since.
Campbell & Co Investment Adviser's Roivant Sciences position peaked at $1.18M in Q2 2025.
500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.